ATE371027T1 - Expressions- und sekretionsvektor für menschliches interferon alpha und verfahren zur herstellung von interferon alpha durch anwendung desselben - Google Patents

Expressions- und sekretionsvektor für menschliches interferon alpha und verfahren zur herstellung von interferon alpha durch anwendung desselben

Info

Publication number
ATE371027T1
ATE371027T1 AT01949005T AT01949005T ATE371027T1 AT E371027 T1 ATE371027 T1 AT E371027T1 AT 01949005 T AT01949005 T AT 01949005T AT 01949005 T AT01949005 T AT 01949005T AT E371027 T1 ATE371027 T1 AT E371027T1
Authority
AT
Austria
Prior art keywords
interferon alpha
human interferon
hifnalpha
same
producing
Prior art date
Application number
AT01949005T
Other languages
English (en)
Inventor
Se Kwon
Sung Youb Jung
Ki Doo Choi
Cha Soon Kim
Sung Bae
Gwan Sun Lee
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Application granted granted Critical
Publication of ATE371027T1 publication Critical patent/ATE371027T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01949005T 2000-01-19 2001-01-19 Expressions- und sekretionsvektor für menschliches interferon alpha und verfahren zur herstellung von interferon alpha durch anwendung desselben ATE371027T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020000002434A KR100360594B1 (ko) 2000-01-19 2000-01-19 인간 인터페론 알파의 발현 분비벡터 및 이를 이용한인터페론 알파의 생산 방법

Publications (1)

Publication Number Publication Date
ATE371027T1 true ATE371027T1 (de) 2007-09-15

Family

ID=19639684

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01949005T ATE371027T1 (de) 2000-01-19 2001-01-19 Expressions- und sekretionsvektor für menschliches interferon alpha und verfahren zur herstellung von interferon alpha durch anwendung desselben

Country Status (14)

Country Link
US (1) US7052867B2 (de)
EP (1) EP1250439B1 (de)
JP (1) JP3751883B2 (de)
KR (1) KR100360594B1 (de)
CN (1) CN100436581C (de)
AT (1) ATE371027T1 (de)
AU (1) AU762053B2 (de)
BR (1) BRPI0107708A8 (de)
CA (1) CA2397527C (de)
DE (1) DE60130100T2 (de)
ES (1) ES2290156T3 (de)
NZ (1) NZ520076A (de)
RU (1) RU2230116C2 (de)
WO (1) WO2001057217A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004004796T2 (de) * 2003-08-13 2007-12-06 Sandoz Ag Expressionsvektoren, transformierte wirtszellen und fermentationsverfahren zur herstellung rekombinanter polypeptide
WO2005017174A2 (en) * 2003-08-13 2005-02-24 Sandoz Ag Process for the purification of recombinant polypeptides
GB0319601D0 (en) * 2003-08-20 2003-09-24 Sandoz Ag Production process
ATE522548T1 (de) 2003-11-13 2011-09-15 Hanmi Holdings Co Ltd Verfahren zur massenproduktion der konstanten region von immunglobulin
US8110665B2 (en) 2003-11-13 2012-02-07 Hanmi Holdings Co., Ltd. Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
EP2195338B1 (de) * 2007-10-01 2013-12-25 Pharmaessentia Corp. N-terminal modifiziertes interferon-alpha
FR2964434B1 (fr) 2010-09-07 2012-08-24 Walden Associates Ltd S A Amortisseur a haut pouvoir dissipatif et pratiquement sans huile
RU2622077C2 (ru) 2011-09-05 2017-06-09 Ханми Сайенс Ко., Лтд. Фармацевтическая композиция для лечения рака, содержащая конъюгат интерферона-альфа
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586386T2 (de) 1984-10-05 1993-01-14 Genentech Inc Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung.
JPS63230089A (ja) 1987-03-18 1988-09-26 Takeda Chem Ind Ltd 分泌発現による蛋白質の製造法
EP0626448A3 (de) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
US5470719A (en) * 1994-03-18 1995-11-28 Meng; Shi-Yuan Modified OmpA signal sequence for enhanced secretion of polypeptides
KR100316347B1 (ko) * 1998-09-15 2002-08-27 한미약품(주) 대장균엔테로톡신ⅱ신호펩티드의변형체와인체성장호르몬의융합단백질을발현하는재조합미생물및그를이용한인체성장호르몬의제조방법

Also Published As

Publication number Publication date
JP2003521925A (ja) 2003-07-22
DE60130100T2 (de) 2008-05-15
AU762053B2 (en) 2003-06-19
EP1250439A4 (de) 2004-04-07
US20040151695A1 (en) 2004-08-05
CN100436581C (zh) 2008-11-26
WO2001057217A1 (en) 2001-08-09
CA2397527A1 (en) 2001-08-09
KR100360594B1 (ko) 2002-11-13
JP3751883B2 (ja) 2006-03-01
AU2890901A (en) 2001-08-14
EP1250439A1 (de) 2002-10-23
RU2230116C2 (ru) 2004-06-10
BR0107708A (pt) 2002-11-19
CA2397527C (en) 2010-10-19
EP1250439B1 (de) 2007-08-22
US7052867B2 (en) 2006-05-30
BRPI0107708A8 (pt) 2016-06-07
CN1418251A (zh) 2003-05-14
WO2001057217A9 (en) 2002-12-27
DE60130100D1 (de) 2007-10-04
ES2290156T3 (es) 2008-02-16
NZ520076A (en) 2003-07-25
KR20010073658A (ko) 2001-08-01

Similar Documents

Publication Publication Date Title
ATE154830T1 (de) Proteinhydrolysate aus erbse, methode zur seiner herstellung und verwendung
DE60230274D1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des pts-g
EP2330199A3 (de) Tensidtolerante Zellulase und Modifikationsverfahren dafür
ATE80660T1 (de) Verfahren zur herstellung eines polypeptides.
NZ510385A (en) E. coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of the MST peptide and a heterologous protein, such as human growth hormone
PT1165791E (pt) Citocina humana como ligando do receptor zalpha e seus usos
ATE371027T1 (de) Expressions- und sekretionsvektor für menschliches interferon alpha und verfahren zur herstellung von interferon alpha durch anwendung desselben
DE59104720D1 (de) Antifungisches polypeptid, verfahren zu seiner herstellung.
DE60021188D1 (de) Modifizierter humaner granulozyten-kolonie stimulierenderfaktor sowie verfahren zur herstellung desselben
ATE455125T1 (de) Tool für den transfer und die herstelung von proteinen mit dem pseudomonas-typ-iii- sekretionssystem
DE69030920D1 (de) Verfahren zur herstellung von pai-2
ATE169013T1 (de) Verfahren zur herstellung von gamma-butyrolacton
DE69533626D1 (de) Tioredioxine h aus zwig und hart-weizen und ähnliche proteine, diese kodierende dna-fragmente und verfahren zu ihrer herstellung
ATE319837T1 (de) Verfahren zur herstellung von rekombinantem trypsin
KR950032626A (ko) 천연 n-말단 서열을 갖는 재조합 아프로티닌 및 재조합 아프로티닌 변형체의 제조 방법
ATE362900T1 (de) Essentielles material und verfahren zu dessen herstellung
DE69031996D1 (de) Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung
ATE346941T1 (de) Protein-disulfidisomerase-gen eines methylotrophen hefestammes
DK1780275T3 (da) Polypeptid med en delta5-fedtsyre-desaturationsaktivitet, polynukleotid kodende for polypeptidet og anvendelse deraf
ATE283909T1 (de) Verfahren zur herstellung von waschmittelgranulaten
EP0945512A3 (de) Serinproteasen
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
ATE470700T1 (de) Bazillus zelle für die herstellung von proteinen
JP2002045190A5 (de)
ATE175668T1 (de) Verfahren zur herstellung von 8-g(a),12-oxido- 13,14,15,16-tetranorlabdan

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties